At the invitation of the Chinese government, Ellogon.ai is exploring the possibility of establishing a presence in China with Gabriele Bani, Wangzhao Song, Robert Kuipers & Hui Cheng🇨🇳 During our initial discussions, pathologists and oncologists showed great interest in our platform EIDOS, which identifies the right patients for cancer immunotherapy. An exciting step towards international collaboration and innovation in AI-driven pathology. In the meantime, three districts in Yancheng province have shown commitment to setting up Ellogon.AI China. To be continued... 🔬✨ #AI #HealthcareInnovation #Pathology #Oncology #Immunotherapy #EllogonAI #EIDOS #China #MedicalAI #PD-L1 #TILs #MSI
Ellogon.AI
Biotechnology Research
Amsterdam, North Holland 1,180 followers
AI for Pathology & Genomics
About us
ELLOGON.AI is working on personalizing immunotherapy with the power of big and rich data, cutting-edge algorithms and a world-class research and development team.
- Website
-
https://ellogon.ai/
External link for Ellogon.AI
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Amsterdam, North Holland
- Type
- Privately Held
- Founded
- 2019
- Specialties
- Artificial Intelligence, Digital and Computational Pathology, Immunotherapy, Medical Imaging, Computer Vision, and Deep Learning
Locations
-
Primary
Get directions
Oudezijds Achterburgwal 237
Amsterdam, North Holland 1012 DL, NL
-
Get directions
Madurastraat 61-3
Amsterdam, North Holland 1094 GG, NL
Employees at Ellogon.AI
Updates
-
Ellogon.AI wishes you all happy holidays! #EIDOS #happyholidays #EllogonAI #biomarkerquantification #sTILs #PDL1